Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

The United Kingdom has planned to use the weight-loss drugs to help unemployed people with obesity to get back to work, ...

In response to the rapid increase in the number of adults taking a weight loss drug - an estimated 18 million adults - health ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The Food and Drug Administration said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Eli Lilly, the US pharmaceutical giant behind weight-loss drugs like Zepbound and Mounjaro, has announced a strategic ...

Britain is investigating if Eli Lilly's weight loss drug, Mounjaro, can help reduce long-term sickness and boost workforce ...

The health secretary believes the latest generation of weight-loss medicine could have a 'monumental' impact on obesity in ...

There was a moment a couple of years ago, as weight-loss injections first erupted into popular consciousness, when it looked ...

The UK plans to test US firm Eli Lilly's weight loss jab Mounjaro to help the burden on the national healthcare system. Over a quarter of UK adults suffered from obesity in 2023 according to ...